*** Up to 10 years of battery longevity at the lowest dose setting: 0.6mA, 500 Ohms, duty cycle 30s on/360s off. Refer to the IFU for additional information. Safety comparisons and specific dose-response curves for each dosage have not been clinically established. NOTE: In neurostimulation therapy, ‘dose’ refers to the delivery of a quantity of energy to tissue. †† Up to 10 years of battery longevity at the lowest dose setting: 0.6mA, 500 Ohms, duty cycle 30s on/360s off. For a list of personal Apple ‡ mobile digital devices compatible with Abbott’s Patient Controller app, visit OR ‡‡ Available on eligible Apple ‡ mobile digital devices. ** Pain and suffering as measured by VAS. † Anywhere with a cellular or Wi-Fi ‡ connection and a sufficiently charged patient controller. * BurstDR™ stimulation superiority when compared to traditional tonic stimulation as studied in SUNBURST ® Bluetooth and Bluetooth logo are registered trademarks of Bluetooth SIG, Inc. ‡ Indicates a third-party trademark, which is property of its respective owner. Be sure to talk to your doctor about the risks associated with the placement of a neurostimulation system. Complications such as infection, swelling, bruising and possibly the loss of strength in or use of an affected limb or muscle group (i.e., paralysis) are possible. ![]() Please note: The placement of the leads is a surgical procedure that exposes you to certain risks. If, at the end of the evaluation period, you and your doctor decide the Proclaim™ Plus or Proclaim™ XR SCS System is right for you, you can choose to have the system implanted. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |